TA 0201

Drug Profile

TA 0201

Alternative Names: T 0201

Latest Information Update: 08 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Tanabe Seiyaku
  • Class Anti-ischaemics; Heart failure therapies
  • Mechanism of Action Endothelin A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart failure; Pulmonary hypertension; Reperfusion injury

Most Recent Events

  • 09 Nov 1999 A preclinical study has been added to the Vascular Disorders pharmacodynamics section
  • 25 Sep 1998 Preclinical development for Pulmonary hypertension in Japan (Unknown route)
  • 25 Sep 1998 Preclinical development for Reperfusion injury in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top